Antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG)_x000D_ _x000D_ CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison’s disease, diabetes melllitus, Crohn’s […]
| Institute |
|---|
| The University of British Columbia |
| Cat. #: | 158317 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Immunology;Neurobiology |
| Application: | ELISA ; FACS ; IHC ; IF ; WB ;DB |
| Target: | C-Type Lectin Domain Containing 16A |
| Reactivity: | Mouse |
| Host: | Rat |
| Class: | Monoclonal |
| Alternate name: | CLEC16A, KIAA35 |
|---|---|
| Product description: | Antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison's disease, diabetes melllitus, Crohn's disease, primary biliary cirrhosis, juvenile idiopathic arthritis, rheumatoid arthritis and multiple sclerosis. . CLEC16A has been shown to regulate various immune pathways including directly regulating leukocyte antigen class II pathway in antigen presenting cells, autophagy, mitophagy, and NK cell cytotoxicity. |
| Conjugation: | Unconjugated |
| Immunogen: | 23-mer C-terminal mouse peptide (CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) linked to KLH |
| Target background: | antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison's disease, diabetes melllitus, Crohn's disease, primary biliary cirrhosis, juvenile idiopathic arthritis, rheumatoid arthritis and multiple sclerosis. . CLEC16A has been shown to regulate various immune pathways including directly regulating leukocyte antigen class II pathway in antigen presenting cells, autophagy, mitophagy, and NK cell cytotoxicity. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.